Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings
Open Access
- 23 September 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (6), 1126-1129
- https://doi.org/10.1093/jac/dkp353
Abstract
The global scale-up of antiretroviral treatment in past years has, unfortunately, not been accompanied by adequate strengthening of laboratory capacity. Monitoring of treatment with HIV viral load and resistance testing, as recommended in industrialized countries, is rarely available in resource-limited settings due to high costs and stringent requirements for storage and transport of plasma. Consequently, treatment failure usually passes unnoticed until severe symptoms occur, when resistance mutations have accumulated and second-line drug options are restricted. Dried blood spots (DBS) are easy to collect and store, and can be a convenient alternative to plasma. Recently, a number of studies have demonstrated the feasibility and reliability of using DBS to monitor viral load and genotypic resistance. Moreover, several African countries have already started to use DBS for paediatric HIV screening. In the absence of point-of-care assays, the WHO should encourage virological monitoring on DBS in antiretroviral treatment programmes in resource-limited settings.This publication has 26 references indexed in Scilit:
- Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural TanzaniaClinical Infectious Diseases, 2009
- Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load TestsJournal of Clinical Microbiology, 2009
- Dried blood spots for the diagnosis and quantitation of HIV-1: Stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in ThailandJournal of Virological Methods, 2009
- No evidence for cross-contamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotypingJournal of Antimicrobial Chemotherapy, 2009
- Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South AfricaAIDS, 2008
- Antiretroviral Treatment of Adult HIV InfectionJAMA, 2008
- Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in AngolaJournal of Antimicrobial Chemotherapy, 2008
- Evaluation of Dried Whole Blood Spots Obtained by Heel or Finger Stick as an Alternative to Venous Blood for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Vertically Exposed Infants in the Routine Diagnostic LaboratoryClinical and Vaccine Immunology, 2007
- Simultaneous Visual Detection of Multiple Viral Amplicons by Dipstick AssayJournal of Clinical Microbiology, 2005
- Multicenter Evaluation of Use of Dried Blood and Plasma Spot Specimens in Quantitative Assays for Human Immunodeficiency Virus RNA: Measurement, Precision, and RNA StabilityJournal of Clinical Microbiology, 2003